Simultaneously, the upregulation of PABPC1 promoted malignant progression in ovarian cancer [19], hepatocellular carcinoma [20], and esophageal squamous cell carcinoma (ESCC) [21]. Here, PABPC1 is linked to esophageal squamous cell carcinoma.